LFMD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
47.3M
-5.7%
50.2M
+608.5%
7.1M
-88.2%
60.2M
+22.8%
49.0M
Cost of Revenue
5.3M
-10.8%
5.9M
+40.0%
4.2M
-42.9%
7.4M
+8.3%
6.8M
Gross Profit
42.0M
-5.1%
44.2M
+1453.3%
2.8M
-94.6%
52.8M
+25.1%
42.2M
Operating Expenses
49.1M
-7.6%
53.2M
+486.1%
9.1M
-83.4%
54.7M
+22.9%
44.5M
R&D
1.8M
-0.3%
1.8M
+295.2%
-920045
-132.3%
2.8M
+56.1%
1.8M
SG&A
44.3M
-1.7%
45.1M
+799.7%
5.0M
-89.1%
46.1M
+15.7%
39.8M
Operating Income
-7129601
+20.2%
-8929072
-43.5%
-6223260
-216.0%
-1969214
+16.1%
-2346886
EBITDA
-5091217
+26.6%
-6932845
+6.1%
-7386763
-822.4%
1.0M
+282.1%
-561541
Net Income
-7083941
+20.2%
-8872596
-144.5%
19.9M
+660.7%
-3556655
-219.1%
-1114589
EPS (Basic)
$-0.16
+20.0%
$-0.20
-148.8%
$0.41
+510.0%
$-0.10
-100.0%
$-0.05
EPS (Diluted)
$-0.16
+20.0%
$-0.20
-148.8%
$0.41
+510.0%
$-0.10
-100.0%
$-0.05
Shares (Diluted)
47.8M
+1.0%
47.3M
+1.1%
46.8M
+1.4%
46.2M
+4.0%
44.4M
LifeMD (LFMD) โ€” Financials